Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-008102
Filing Date
2011-11-07
Accepted
2011-11-07 08:00:26
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q novabay_10q-093011.htm 10-Q 935108
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11772
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11696
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5905
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5787
  Complete submission text file 0001437749-11-008102.txt   3411524

Data Files

Seq Description Document Type Size
6 nby-20110930.xml EX-101.INS 586217
7 nby-20110930.xsd EX-101.SCH 14385
8 nby-20110930_cal.xml EX-101.CAL 29889
9 nby-20110930_def.xml EX-101.DEF 72195
10 nby-20110930_lab.xml EX-101.LAB 99809
11 nby-20110930_pre.xml EX-101.PRE 82721
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 111182857
SIC: 2834 Pharmaceutical Preparations